© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Gabexate Mesylate goes by several names in various chemical catalogs, but under any label, this compound functions as a synthetic serine protease inhibitor. Structurally, it’s derived from benzamidine and ethyl isothiourea, bound in an ester linkage and brought together with a methanesulfonate moiety. This results in a molecule recognized for interfering with the activity of proteolytic enzymes. Practical use traces back to clinical management of pancreatitis and conditions like disseminated intravascular coagulation. For chemical professionals and end users, knowing this background informs both safe handling and applications.
Gabexate Mesylate tends to appear as a white to off-white crystalline powder, although laboratory batches sometimes yield fine flakes rather than a compact powder. Chemists examine the melting point, which hovers near 150°C, a detail that guides storage and formulation planning. The compound’s molecular formula is C20H23N3O5S, with a molar mass calculated at 433.48 g/mol. Historically significant for its high water solubility, Gabexate Mesylate forms a clear solution up to moderate concentrations (commonly 10 mg/mL), which simplifies both intravenous administration and analytical work.
Density for Gabexate Mesylate usually settles at about 1.2 g/cm3 in powders. The compound doesn’t exhibit hazardous volatility or present off-putting odors; in fact, many in laboratory and manufacturing environments comment on its relative stability compared with volatile organics or caustic acids. Crystal particles often display a “pearl-like” luster under magnification, with a solid but brittle texture that powders easily.
The key feature for Gabexate Mesylate rests in its benzamidine core, which blocks protease activity at a molecular level. This structure is built on firm carbon-nitrogen and carbon-oxygen bonds, holding up well under ordinary lab conditions. Gabexate Mesylate’s specific gravity and crystalline stability matter in applications that require predictable solubility and uniform dissolution. Laboratory tests bear out low rates of degradation in dry storage, although moisture and extreme pH swing can lead to breakdown. These molecular properties enable precise management during both formulation and delivery.
Gabexate Mesylate is assigned a Harmonized System Code (HS Code) under 2933.59, which covers heterocyclic compounds containing nitrogen hetero-atom(s) only. This code connects importers and chemical suppliers across international borders, simplifying customs processing and trade compliance. Purity specification in pharmaceutical contexts usually exceeds 98%, confirmed by analytical HPLC or TLC methods. Bulk packaging often relies on opaque, moisture-proof containers, while lab-scale orders arrive in sealed amber vials meant to resist light-induced degradation.
Gabexate Mesylate’s commercial forms support a range of uses. The powder dissolves quickly in aqueous buffers, making it ideal for formulation or immediate analytical procedures. Solid, flake, and pearl forms appear less often, but some handlers prefer them for accurate weighing and minimal dusting. Crystal grade appeals to those setting up high-purity reactions or crystallography studies. In medical settings and research, solutions prepared to precise concentrations offer reliability from batch to batch. The choice between solid and solution form hinges on intended use, shelf life requirements, and the convenience of the final delivery method.
Gabexate Mesylate does not present hazards typical of strong acids, volatile solvents, or pyrophoric reagents, yet risks remain for those working with concentrated powders or solutions. Splashes cause mild eye and skin irritation; chronic inhalation hasn’t been tied to long-term harm, but a dust mask and gloves remain standard precautions. Material Safety Data Sheets list it as a harmful substance when ingested in large amounts, highlighting the need for clear labeling and restricted access in non-clinical environments. For transport and storage, routine chemical safety practices—sealed containers, dry environments, clear hazard communication—keep risks manageable.
Production of Gabexate Mesylate draws from stable, well-regulated chemical feedstocks: ethyl p-aminobenzoate, amidine derivatives, and p-toluenesulfonic acid, among others. This keeps sourcing relatively straightforward for pharmaceutical manufacturers and chemical suppliers. Supply chain reliability results from broad global demand, particularly as hospitals and clinics implement the compound for acute medical management. Regulatory agencies watch production chains closely, given Gabexate Mesylate’s status as a finished drug ingredient. End users benefit from transparent, well-documented sourcing, which meets standards for traceability and minimizes concerns over impurities or contamination.
Efficient storage strategies include vacuum-sealed packaging and silica gel pouches to block moisture ingress. Facilities designing chemical storage rooms install controlled humidity and temperature settings, keeping Gabexate Mesylate within its optimal stability zone. For handlers dealing with powder spills, high-efficiency particulate air (HEPA) filtering and static-reducing surfaces simplify cleanup. Sourcing conflicts drop when companies commit to traceable, high-quality supply partners who share batch-level analytical data. Training lab technicians and warehouse staff on the specifics of Gabexate Mesylate’s properties ensures that handling mistakes, mix-ups, or contamination events drop significantly in both frequency and impact.
Gabexate Mesylate matters not just as a clinical tool, but as a backbone for experimental research on enzyme interactions. Its inhibitory mechanisms give pharmacologists and biochemists a window into the deeper workings of proteases—enzymes at the core of inflammation, coagulation, and cellular breakdown. By anchoring laboratory protocols with a compound that resists rapid breakdown and presents few extraneous hazards, research teams run more reproducible, reliable studies. For hospitals and care providers, Gabexate Mesylate’s stability in solution makes it a dependable choice for urgent therapeutic settings, often described as straightforward to formulate and dose.
